Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun;17(6):1577-1588.
doi: 10.1111/os.70019. Epub 2025 Mar 16.

The Choice of Hip Arthroplasty: HRA or THA? Revealed by Meta-Analysis

Affiliations
Review

The Choice of Hip Arthroplasty: HRA or THA? Revealed by Meta-Analysis

Xiao Fan et al. Orthop Surg. 2025 Jun.

Abstract

Background: Total hip arthroplasty (THA) is the gold standard for end-stage hip arthrosis, while hip resurfacing arthroplasty (HRA) is considered a more bone-conserving alternative. This meta-analysis aimed to compare the safety and clinical efficacy of HRA and THA.

Methods: The databases of PubMed, EMBASE, Cochrane Library, and CNKI were searched for RCTs comparing HRA and THA in treating hip arthrosis from database initiation to April 2024. Inclusion and exclusion criteria were defined, and data extraction, quality evaluation, and risk bias assessment were performed. A meta-analysis was conducted using appropriate RevManv5.4 and Stata v14.0 software.

Results: Twenty RCTs from six countries were included. HRA had a similar revision rate, function scores (WOMAC, HSS, OHS, UCLA activity score, EQ-D, EQ-5D VAS), and blood levels of cobalt and chromium compared to THA. HRA had fewer complications and less blood loss but required more operating time.

Conclusions: HRA is a safe and effective alternative to THA, with similar revision and functional outcomes, less blood loss, and is particularly suitable for young male patients with a demand for high-level activities.

Keywords: clinical efficacy; hip arthrosis; hip resurfacing arthroplasty (HRA); meta‐analysis; safety; systematic review; total hip arthroplasty (THA).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Flow chart of document retrieval process.
FIGURE 2
FIGURE 2
Risk of bias assessment results included in RCTs (Cochrane Manual of Systematic Reviews).
FIGURE 3
FIGURE 3
Revision rate.
FIGURE 4
FIGURE 4
WOMAC.
FIGURE 5
FIGURE 5
OHS.
FIGURE 6
FIGURE 6
HHS.
FIGURE 7
FIGURE 7
UCLA activity score.
FIGURE 8
FIGURE 8
EQ‐5D.
FIGURE 9
FIGURE 9
EQ‐5D VAS.
FIGURE 10
FIGURE 10
Blood levels of cobalt.
FIGURE 11
FIGURE 11
Blood levels of chromium.
FIGURE 12
FIGURE 12
Complications.
FIGURE 13
FIGURE 13
Blood loss.
FIGURE 14
FIGURE 14
Operating time.
FIGURE 15
FIGURE 15
Operation time subgroup.
FIGURE 16
FIGURE 16
Complications funnel plot.

References

    1. Okafor L. and Chen A. F., “Patient Satisfaction and Total Hip Arthroplasty: A Review,” Arthroplasty 1, no. 1 (2019): 6. - PMC - PubMed
    1. Alagha M. A., Logishetty K., O'Hanlon C., Liddle A. D., and Cobb J., “Three‐Dimensional Preoperative Planning Software for Hip Resurfacing Arthroplasty,” Bioengineering 10, no. 8 (2023): 939, 10.3390/bioengineering10080939. - DOI - PMC - PubMed
    1. Al‐Jabri T., Ridha M., McCulloch R. A., et al., “Hip Resurfacing Arthroplasty: Past, Present and Future,” Orthopedic Reviews 15 (2023): 77745, 10.52965/001c.77745. - DOI - PMC - PubMed
    1. LeBrun D. G., Shen T. S., Bovonratwet P., Morgenstern R., and Su E. P., “Hip Resurfacing vs Total Hip Arthroplasty in Patients Younger Than 35 Years: A Comparison of Revision Rates and Patient‐Reported Outcomes,” Arthroplast Today 11 (2021): 229–233. - PMC - PubMed
    1. Rueckl K., Liebich A., Bechler U., Springer B., Rudert M., and Boettner F., “Return to Sports After Hip Resurfacing Versus Total Hip Arthroplasty: A Mid‐Term Case Control Study,” Archives of Orthopaedic and Trauma Surgery 140, no. 7 (2020): 957–962. - PubMed

MeSH terms